Deborah J Watkins1, Brisa N Sánchez2, Martha Maria Téllez-Rojo3, Joyce M Lee4, Adriana Mercado-García3, Clara Blank-Goldenberg5, Karen E Peterson6, John D Meeker7. 1. Department of Environmental Health Sciences, University of Michigan School of Public Health, Ann Arbor, MI, USA. Electronic address: debjwat@umich.edu. 2. Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI, USA. 3. Center for Nutrition and Health Research, Instituto Nacional de Salud Pública, Cuernavaca, MOR, Mexico. 4. Department of Environmental Health Sciences, University of Michigan School of Public Health, Ann Arbor, MI, USA; Pediatric Endocrinology, Child Health Evaluation and Research Unit (CHEAR), University of Michigan, Ann Arbor, MI, USA. 5. American British Cowdray (ABC) Hospital, Mexico City, Mexico. 6. Department of Nutritional Sciences, University of Michigan School of Public Health, Ann Arbor, MI, USA; Center for Human Growth and Development, University of Michigan, Ann Arbor, MI, USA. 7. Department of Environmental Health Sciences, University of Michigan School of Public Health, Ann Arbor, MI, USA.
Abstract
BACKGROUND: Over the past several decades, the age of pubertal onset in girls has shifted downward worldwide. As early pubertal onset is associated with increased risky behavior and psychological issues during adolescence and cardiometabolic disease and cancer in adulthood, this is an important public health concern. Exposure to endocrine disrupting chemicals during critical windows of in utero development may play a role in this trend. Our objective was to investigate trimester-specific phthalate and BPA exposure in relation to pubertal development among girls in the Early Life Exposure in Mexico to Environmental Toxicants (ELEMENT) birth cohort. METHODS: We measured maternal urinary phthalate metabolites and BPA in samples collected during the first, second, and third trimesters of pregnancy. To assess reproductive development among their female children, we measured serum testosterone, estradiol, dehydroepiandrosterone sulfate (DHEA-S), inhibin B, and sex hormone-binding globulin (SHBG), and assessed sexual maturation, including Tanner staging for breast and pubic hair development and menarche status, at age 8-13 years (n = 120). We used linear and logistic regression to examine measures of trimester-specific in utero exposure as predictors of peripubertal hormone levels and pubertal onset, respectively. In secondary analyses, we evaluated estimated exposure at the midpoint of the first trimester and rates of change in exposure across pregnancy in relation to outcomes. RESULTS: Several phthalate metabolites measured throughout in utero development were associated with higher serum testosterone concentrations, while a number of metabolites measured in the third trimester were associated with higher DHEA-S. For example, an interquartile range (IQR) increase in mean monoethyl phthalate (MEP) levels across pregnancy was associated with 44% higher peripubertal testosterone (95% CI: 13-83%), while an IQR increase in di-2-ethylhexyl phthalate metabolites (ΣDEHP) specifically in the third trimester was associated with 25% higher DHEA-S (95%CI: 4.7-47%). In IQR increase in mean mono-2-ethylhexyl phthalate (MEHP) levels across pregnancy was associated with lower odds of having a Tanner Stage >1 for breast development (OR = 0.32, 95%CI: 0.11-0.95), while MEHP in the third trimester was associated with higher odds of having a Tanner Stage >1 for pubic hair development (OR = 3.76, 95%CI: 1.1-12.8). Results from secondary analyses were consistent with findings from our main analysis. CONCLUSION: These findings suggest that female reproductive development may be more vulnerable to the effects of phthalate or BPA exposure during specific critical periods of in utero development. This highlights the need for comprehensive characterizations of in utero exposure and consideration of windows of susceptibility in developmental epidemiological studies. Future research should consider repeated measures of in utero phthalate and BPA exposure within each trimester and across pregnancy.
BACKGROUND: Over the past several decades, the age of pubertal onset in girls has shifted downward worldwide. As early pubertal onset is associated with increased risky behavior and psychological issues during adolescence and cardiometabolic disease and cancer in adulthood, this is an important public health concern. Exposure to endocrine disrupting chemicals during critical windows of in utero development may play a role in this trend. Our objective was to investigate trimester-specific phthalate and BPA exposure in relation to pubertal development among girls in the Early Life Exposure in Mexico to Environmental Toxicants (ELEMENT) birth cohort. METHODS: We measured maternal urinary phthalate metabolites and BPA in samples collected during the first, second, and third trimesters of pregnancy. To assess reproductive development among their female children, we measured serum testosterone, estradiol, dehydroepiandrosterone sulfate (DHEA-S), inhibin B, and sex hormone-binding globulin (SHBG), and assessed sexual maturation, including Tanner staging for breast and pubic hair development and menarche status, at age 8-13 years (n = 120). We used linear and logistic regression to examine measures of trimester-specific in utero exposure as predictors of peripubertal hormone levels and pubertal onset, respectively. In secondary analyses, we evaluated estimated exposure at the midpoint of the first trimester and rates of change in exposure across pregnancy in relation to outcomes. RESULTS: Several phthalate metabolites measured throughout in utero development were associated with higher serum testosterone concentrations, while a number of metabolites measured in the third trimester were associated with higher DHEA-S. For example, an interquartile range (IQR) increase in mean monoethyl phthalate (MEP) levels across pregnancy was associated with 44% higher peripubertal testosterone (95% CI: 13-83%), while an IQR increase in di-2-ethylhexyl phthalate metabolites (ΣDEHP) specifically in the third trimester was associated with 25% higher DHEA-S (95%CI: 4.7-47%). In IQR increase in mean mono-2-ethylhexyl phthalate (MEHP) levels across pregnancy was associated with lower odds of having a Tanner Stage >1 for breast development (OR = 0.32, 95%CI: 0.11-0.95), while MEHP in the third trimester was associated with higher odds of having a Tanner Stage >1 for pubic hair development (OR = 3.76, 95%CI: 1.1-12.8). Results from secondary analyses were consistent with findings from our main analysis. CONCLUSION: These findings suggest that female reproductive development may be more vulnerable to the effects of phthalate or BPA exposure during specific critical periods of in utero development. This highlights the need for comprehensive characterizations of in utero exposure and consideration of windows of susceptibility in developmental epidemiological studies. Future research should consider repeated measures of in utero phthalate and BPA exposure within each trimester and across pregnancy.
Authors: Chunyan He; Cuilin Zhang; David J Hunter; Susan E Hankinson; Germaine M Buck Louis; Mary L Hediger; Frank B Hu Journal: Am J Epidemiol Date: 2009-12-21 Impact factor: 4.897
Authors: Rajalakshmi Lakshman; Nita G Forouhi; Stephen J Sharp; Robert Luben; Sheila A Bingham; Kay-Tee Khaw; Nicholas J Wareham; Ken K Ong Journal: J Clin Endocrinol Metab Date: 2009-10-30 Impact factor: 5.958
Authors: David E Cantonwine; José F Cordero; Luis O Rivera-González; Liza V Anzalota Del Toro; Kelly K Ferguson; Bhramar Mukherjee; Antonia M Calafat; Noe Crespo; Braulio Jiménez-Vélez; Ingrid Y Padilla; Akram N Alshawabkeh; John D Meeker Journal: Environ Int Date: 2013-10-24 Impact factor: 9.621
Authors: Antonia M Calafat; Matthew P Longnecker; Holger M Koch; Shanna H Swan; Russ Hauser; Lynn R Goldman; Bruce P Lanphear; Ruthann A Rudel; Stephanie M Engel; Susan L Teitelbaum; Robin M Whyatt; Mary S Wolff Journal: Environ Health Perspect Date: 2015-07 Impact factor: 9.031
Authors: Manori J Silva; Dana B Barr; John A Reidy; Nicole A Malek; Carolyn C Hodge; Samuel P Caudill; John W Brock; Larry L Needham; Antonia M Calafat Journal: Environ Health Perspect Date: 2004-03 Impact factor: 9.031
Authors: Katherine W Reeves; Mary Díaz Santana; JoAnn E Manson; Susan E Hankinson; R Thomas Zoeller; Carol Bigelow; Susan R Sturgeon; Donna Spiegelman; Lesley Tinker; Juhua Luo; Bertha Chen; Jaymie Meliker; Matthew R Bonner; Michele L Cote; Ting-Yuan David Cheng; Antonia M Calafat Journal: J Natl Cancer Inst Date: 2019-10-01 Impact factor: 13.506
Authors: Amber Cathey; Deborah J Watkins; Brisa N Sánchez; Marcela Tamayo-Ortiz; Maritsa Solano-Gonzalez; Libni Torres-Olascoaga; Martha Maria Téllez-Rojo; Karen E Peterson; John D Meeker Journal: Environ Int Date: 2020-01-10 Impact factor: 9.621
Authors: Sarah Zulkifli; Amirah Abdul Rahman; Siti Hamimah Sheikh Abdul Kadir; Noor Shafina Mohd Nor Journal: Eur J Pediatr Date: 2021-04-24 Impact factor: 3.183
Authors: Kim G Harley; Kimberly P Berger; Katherine Kogut; Kimberly Parra; Robert H Lustig; Louise C Greenspan; Antonia M Calafat; Xiaoyun Ye; Brenda Eskenazi Journal: Hum Reprod Date: 2019-01-01 Impact factor: 6.918
Authors: Deborah J Watkins; John D Meeker; Marcela Tamayo-Ortiz; Brisa N Sánchez; Lourdes Schnaas; Karen E Peterson; Martha María Téllez-Rojo Journal: Environ Res Date: 2021-02-25 Impact factor: 6.498
Authors: Pooja Tyagi; Tamarra James-Todd; Lidia Mínguez-Alarcón; Jennifer B Ford; Myra Keller; John Petrozza; Antonia M Calafat; Russ Hauser; Paige L Williams; Andrea Bellavia Journal: Environ Res Date: 2020-12-25 Impact factor: 6.498